Table 3 Gelatin-containing vaccines approved for use in the United States (black type) and Europe (blue type) 2015

Influenza (Fluzone [only in standard dose trivalent IM], Sanofi Pasteur)

250 micrograms per 0.5 ml dose

Influenza (FluMist, MedImmune Vaccines)

2000 micrograms per 0.2 ml dose

Influenza (Fluenz Tetra, MedImmune LLC)

Unspecified amount^a hydrolyzed gelatin, type A per 0.2 ml dose

Measles, Mumps, Rubella (MMRII, Merck)

14,500 micrograms per 0.5 ml dose

Measles, Mumps, Rubella, Varicella (M-M-RVAXPRO, Sanofi Pasteur)

Unspecified amount^a hydrolyzed gelatin per 0.5 ml dose

Measles, Mumps, Rubella, Varicella (ProQuad, Merck)

11,000 micrograms per 0.5 ml dose

Measles, Mumps, Rubella, Varicella (ProQuad, marketed in Europe by Sanofi Pasteur)

Unspecified amount^a hydrolyzed gelatin per 0.5 ml dose

Rabies (RabAvert, Novartis)

12,000 micrograms per 1.0 ml dose

Typhoid Vaccine Live Oral Ty21a (Vivotif, Crucell)

Capsule

Varicella (VARIVAX, Merck)

12,500 micrograms per 0.5 ml dose

Yellow Fever (YF-VAX, Sanofi Pasteur)

7,500 micrograms per 0.5 ml dose

Zoster (ZOSTAVAX, Merck)

15,580 micrograms per 0.65 ml dose

Zoster (ZOSTAVAX, marketed in Europe by Sanofi Pasteur)

Unspecified amount^a hydrolyzed gelatin per 0.65 ml dose